Lord, Abbett & Co. LLC Guardant Health, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $31.4 Billion
  • Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 681,074 shares of GH stock, worth $21.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
681,074
Previous 681,074 -0.0%
Holding current value
$21.6 Million
Previous $15.6 Million -0.0%
% of portfolio
0.05%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$22.3 - $36.29 $15.2 Million - $24.7 Million
681,074 New
681,074 $15.6 Million
Q3 2023

Oct 07, 2024
BUY
$25.8 - $39.97 $5.15 Million - $7.98 Million
199,756 Added 44.87%
644,964 $19.1 Million
Q3 2023

Nov 13, 2023
BUY
$25.8 - $39.97 $5.15 Million - $7.98 Million
199,756 Added 44.87%
644,964 $19.1 Million
Q2 2023

Oct 07, 2024
BUY
$20.94 - $38.01 $9.32 Million - $16.9 Million
445,208 New
445,208 $15.9 Million
Q2 2023

Aug 14, 2023
BUY
$20.94 - $38.01 $9.32 Million - $16.9 Million
445,208 New
445,208 $15.9 Million
Q2 2021

Aug 11, 2021
SELL
$109.77 - $165.68 $8.8 Million - $13.3 Million
-80,196 Closed
0 $0
Q1 2021

May 11, 2021
SELL
$127.04 - $179.1 $32.3 Million - $45.5 Million
-254,099 Reduced 76.01%
80,196 $12.2 Million
Q4 2020

Feb 09, 2021
BUY
$99.96 - $135.93 $3.39 Million - $4.6 Million
33,868 Added 11.27%
334,295 $43.1 Million
Q3 2020

Nov 12, 2020
BUY
$80.32 - $111.8 $948,659 - $1.32 Million
11,811 Added 4.09%
300,427 $33.6 Million
Q2 2020

Aug 14, 2020
SELL
$60.49 - $97.5 $3.5 Million - $5.65 Million
-57,903 Reduced 16.71%
288,616 $23.4 Million
Q1 2020

May 14, 2020
SELL
$59.04 - $88.81 $201,975 - $303,819
-3,421 Reduced 0.98%
346,519 $24.1 Million
Q4 2019

Feb 14, 2020
BUY
$59.49 - $82.78 $6.52 Million - $9.08 Million
109,651 Added 45.63%
349,940 $27.3 Million
Q3 2019

Nov 14, 2019
SELL
$62.59 - $110.3 $46.8 Million - $82.4 Million
-747,079 Reduced 75.66%
240,289 $15.3 Million
Q2 2019

Aug 14, 2019
BUY
$63.94 - $91.11 $38.6 Million - $55 Million
603,938 Added 157.51%
987,368 $85.2 Million
Q1 2019

May 15, 2019
SELL
$34.3 - $97.98 $5.12 Million - $14.6 Million
-149,276 Reduced 28.02%
383,430 $29.4 Million
Q4 2018

Feb 14, 2019
BUY
$29.2 - $46.1 $15.6 Million - $24.6 Million
532,706 New
532,706 $20 Million

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.24B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email